This compound is a pharmaceutical intermediate featuring an azetidine ring with a hydroxymethyl substituent and a tert-butoxycarbonyl protecting group. It is primarily used in the synthesis of active pharmaceutical ingredients.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 142253-56-3
2,6-Heptadienoic acid, 7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-5-hydroxy-, (2Z,5S,6E)-
Pharmaceutical intermediate for drug synthesis
6-~{tert}-Butyl-8-Fluoranyl-2-[3-(Hydroxymethyl)-4-[1-Methyl-5-[[5-(1-Methylpiperidin-4-Yl)pyridin-2-Yl]amino]-6-Oxidanylidene-Pyridazin-3-Yl]pyridin-2-Yl]phthalazin-1-One
BTK inhibitor intermediate
((((2-(6-Amino-9H-purin-9-yl)ethoxy)methyl)(ethoxy)phosphoryl)oxy)methyl pivalate
prodrug intermediate for adefovir
Tert-Butyl (6-bromohexyl)carbamate
building block for pharmaceutical synthesis
Tert-butyl 3-hydroxyazetidine-1-carboxylate
protected building block for synthesis
Tert-butyl 3-iodoazetidine-1-carboxylate
Pharmaceutical intermediate for synthesis
3-Methoxyazetidine hydrochloride
Research reagent
1-[(tert-butoxy)carbonyl]azetidine-2-carboxylic acid
Pharmaceutical intermediate for peptide synthesis
tert-butyl 3-(hydroxymethyl)azetidine-1-carboxylate
HXRDRJKAEYHOBB-UHFFFAOYSA-N
CC(C)(C)OC(=O)N1CC(C1)CO